According to the Zhitong Finance App, Qingcheng New Pharmaceutical-B (02396.HK) issued an announcement. Ms. Jia Lijia, chairman of the board of directors and executive director, has been appointed as the company's Chief Executive Officer (CEO) with effect from October 20, 2026. His term as CEO will end on the day the first term of the board expires.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.